Andrew J Murphy Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Andrew J Murphy is EVP Research of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,121 shares of REGN, which is worth approximately $35 Million. The most recent transaction as insider was on Aug 15, 2022, when has been sold 6,487 shares (Common Stock) at a price of $634.25 per share, resulting in proceeds of $4,114,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.1K

2.45% 3M change

20.7% 12M change

Total Value Held $35 Million

ANDREW J MURPHY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2022	SELL Payment of exercise price or tax liability	$4,114,380 $634.25 p/Share	6,487 Reduced 9.47%	61,983 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$1,791,300 $179.13 p/Share	10,000 Added 12.74%	68,470 Common Stock
May 17 2022	SELL Open market or private sale	$2,349,647 $663.18 p/Share	3,543 Reduced 5.71%	58,470 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$4,186,138 $648.31 p/Share	6,457 Reduced 9.43%	62,013 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$1,791,300 $179.13 p/Share	10,000 Added 12.74%	68,470 Common Stock
Feb 15 2022	SELL Open market or private sale	$2,227,864 $629.34 p/Share	3,540 Reduced 5.71%	58,470 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$4,049,063 $626.79 p/Share	6,460 Reduced 9.43%	62,010 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	$1,791,300 $179.13 p/Share	10,000 Added 12.74%	68,470 Common Stock
Dec 11 2021	SELL Payment of exercise price or tax liability	$463,045 $664.34 p/Share	697 Reduced 1.18%	58,470 Common Stock
Dec 10 2021	SELL Open market or private sale	$4,735,916 $664.97 p/Share	7,122 Reduced 10.74%	59,167 Common Stock
Dec 09 2021	SELL Payment of exercise price or tax liability	$6,162,377 $657.11 p/Share	9,378 Reduced 12.39%	66,289 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	$858,495 $52.03 p/Share	16,500 Added 17.9%	75,667 Common Stock
Dec 08 2021	BUY Grant, award, or other acquisition	-	3,462 Added 5.53%	59,167 Common Stock
Nov 16 2021	SELL Open market or private sale	$4,666,864 $651.16 p/Share	7,167 Reduced 11.4%	55,705 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$6,037,798 $641.5 p/Share	9,412 Reduced 13.02%	62,872 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$862,605 $52.03 p/Share	16,579 Added 18.66%	72,284 Common Stock
Aug 16 2021	SELL Bona fide gift	-	1,645 Reduced 2.87%	55,705 Common Stock
Dec 09 2020	BUY Grant, award, or other acquisition	-	10,214 Added 15.12%	57,350 Common Stock
Nov 17 2020	SELL Open market or private sale	$3,616,303 $545.61 p/Share	6,628 Reduced 12.33%	47,136 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$3,990,360 $561.39 p/Share	7,108 Reduced 11.68%	53,764 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$420,734 $30.63 p/Share	13,736 Added 18.41%	60,872 Common Stock
Oct 22 2020	BUY Exercise of conversion of derivative security	$214,296 $41.33 p/Share	5,185 Added 9.91%	47,136 Common Stock

AJM

Andrew J Murphy

EVP Research

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account